These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 1127382)

  • 21. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis.
    Trotter JL; Ringel SP; Cook JD; Engel WK; Eldefrawi ME; McFarlin DE
    Neurology; 1977 Dec; 27(12):1120-4. PubMed ID: 73154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
    Karussis DM; Lehmann D; Brenner T; Wirguin I; Mizrachi-Koll R; Sicsic C; Abramsky O
    J Neuroimmunol; 1994 Dec; 55(2):187-93. PubMed ID: 7829669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR
    Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease.
    Moiola L; Galbiati F; Martino G; Amadio S; Brambilla E; Comi G; Vincent A; Grimaldi LM; Adorini L
    Eur J Immunol; 1998 Aug; 28(8):2487-97. PubMed ID: 9710226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Animal models of myasthenia gravis.
    Christadoss P; Poussin M; Deng C
    Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenia gravis as a prototype autoimmune receptor disease.
    Hoedemaekers AC; van Breda Vriesman PJ; De Baets MH
    Immunol Res; 1997; 16(4):341-54. PubMed ID: 9439759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
    Biesecker G; Koffler D
    J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental myasthenia gravis. A murine system.
    Berman PW; Patrick J
    J Exp Med; 1980 Jan; 151(1):204-23. PubMed ID: 7350247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental autoimmune myasthenia gravis induced by thymic acetylcholine receptor-like protein.
    Kawanami S; Mori S
    Fukuoka Igaku Zasshi; 1994 Apr; 85(4):120-7. PubMed ID: 8200609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental autoimmune myasthenia gravis and CD5+ B-lymphocyte expression.
    Lee KW; Lee SH; Kim HJ; Kim JM; Choi YM; Motomura M
    J Korean Med Sci; 1999 Feb; 14(1):75-9. PubMed ID: 10102528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis.
    Lennon VA; Lambert EH; Leiby KR; Okarma TB; Talib S
    J Immunol; 1991 Apr; 146(7):2245-8. PubMed ID: 2005394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of experimental autoimmune myasthenia gravis by a monoclonal antibody to a complementary peptide for the main immunogenic region of the acetylcholine receptors.
    Araga S; Galin FS; Kishimoto M; Adachi A; Blalock JB
    J Immunol; 1996 Jul; 157(1):386-92. PubMed ID: 8683141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):293-6, 320. PubMed ID: 2282884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM; Richman DP
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis.
    De Baets MH; Verschuuren J; Daha MR; van Breda Vriesman PJ
    Immunol Res; 1988; 7(3):200-11. PubMed ID: 3264006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.